Wikidata entity: Q415264
Quantities
| P4250 | defined daily dose | 3.75 |
| P3780 | active ingredient in | ... | Q29005875 (Flixabi) | Flixabi |
| P3780 | active ingredient in | ... | Q29005987 (Inflectra) | Inflectra |
| P3780 | active ingredient in | ... | Q29006415 (Remicade) | Remicade |
| P3780 | active ingredient in | ... | Q29006417 (Remsima) | Remsima |
| P373 | Commons category | String | Infliximab | ??? |
| P1552 | has characteristic | ... | Q679692 (biopharmaceutical) | biopharmaceutical |
| P366 | has use | ... | Q12140 (medication) | medication |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Infliximab%20structure2.jpg | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83283320 (LiverTox toxicity likelihood category A) | LiverTox toxicity likelihood category A |
| P2175 | medical condition treated | ... | Q1477 (ulcerative colitis) | ulcerative colitis |
| P2175 | medical condition treated | ... | Q52849 (ankylosing spondylitis) | ankylosing spondylitis |
| P2175 | medical condition treated | ... | Q265936 (Kawasaki disease) | Kawasaki disease |
| P2175 | medical condition treated | ... | Q170990 (arthritis) | arthritis |
| P2175 | medical condition treated | ... | Q432462 (Takayasu's arteritis) | Takayasu's arteritis |
| P2175 | medical condition treated | ... | Q280027 (uveitis) | uveitis |
| P2175 | medical condition treated | ... | Q838966 (irritable bowel syndrome) | irritable bowel syndrome |
| P2175 | medical condition treated | ... | Q911427 (Behçet's disease) | Behçet's disease |
| P2175 | medical condition treated | ... | Q1274464 (polyarthritis) | polyarthritis |
| P2175 | medical condition treated | ... | Q1526459 (pyoderma gangrenosum) | pyoderma gangrenosum |
| P2175 | medical condition treated | ... | Q2165411 (spondylitis) | spondylitis |
| P2175 | medical condition treated | ... | Q2453464 (colitis) | colitis |
| P3489 | pregnancy category | ... | Q3679261 (Australian pregnancy category C) | Australian pregnancy category C |
| P3489 | pregnancy category | ... | Q28123616 (US pregnancy category B) | US pregnancy category B |
| P636 | route of administration | ... | Q640448 (intravenous infusion and defusion) | intravenous infusion and defusion |
| P9989 | stylized name | String | inFLIXimab | ??? |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q422248 (monoclonal antibody) | monoclonal antibody |
| P2868 | subject has role | ... | Q1809112 (dermatologic drug) | dermatologic drug |
| P2868 | subject has role | ... | Q810254 (disease-modifying antirheumatic drug) | disease-modifying antirheumatic drug |
| P2868 | subject has role | ... | Q50349184 (immunologic factor) | immunologic factor |
| P2868 | subject has role | ... | Q50377202 (gastrointestinal agent) | gastrointestinal agent |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | إينفليكسيماب | ??? |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | infliximab | ??? |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | infliximab | ??? |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | infliximab | ??? |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | infliximabum | ??? |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | инфликсимаб | ??? |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | 英利昔单抗 | ??? |
| P267 | ATC code | L04AB02 |
| P5019 | Brockhaus Enzyklopädie online ID | infliximab |
| P231 | CAS Registry Number | 170277-31-3 |
| P592 | ChEMBL ID | CHEMBL1201581 |
| P9272 | DeCS ID | 55983 |
| P715 | DrugBank ID | DB00065 |
| P3117 | DSSTox substance ID | DTXSID9040504 |
| P9635 | electronic Essential Medicines List medicine ID | 549 |
| P1417 | Encyclopædia Britannica Online ID | topic/infliximab |
| P646 | Freebase ID | /m/01vzrk |
| P595 | Guide to Pharmacology Ligand ID | 5004 |
| P2062 | HSDB ID | 7850 |
| P665 | KEGG ID | D02598 |
| P7830 | LiverTox ID | Infliximab |
| P10245 | MedlinePlus drug identifier | a604023 |
| P486 | MeSH descriptor ID | D000069285 |
| P672 | MeSH tree code | D12.776.124.486.485.114.224.608 |
| P672 | MeSH tree code | D12.776.124.790.651.114.224.537 |
| P672 | MeSH tree code | D12.776.377.715.548.114.224.642 |
| P6366 | Microsoft Academic ID (discontinued) | 2777138892 |
| P6366 | Microsoft Academic ID (discontinued) | 2910408542 |
| P950 | National Library of Spain SpMaBN ID (BNE v1.0) | XX551354 |
| P2115 | NDF-RT ID | N0000148580 |
| P3221 | New York Times topic ID | subject/remicade-drug |
| P2840 | NSC number | 728729 |
| P10283 | OpenAlex ID | C2777138892 |
| P4235 | PatientsLikeMe treatment ID | infliximab |
| P3417 | Quora topic ID | Infliximab |
| P3345 | RxNorm CUI | 191831 |
| P5082 | Store medisinske leksikon ID | infliksimab |
| P2892 | UMLS CUI | C0666743 |
| P652 | UNII | B72HH48FLU |
| P11143 | WikiProjectMed ID | Infliximab |
| P8814 | WordNet 3.1 Synset ID | 03574837-n |
| P3350 | World Health Organisation international non-proprietary name numeric ID | 7602 |
Why not click here or view trends?
log id: 1099635